Pharmacokinetics and pharmacodynamics comparison of two pegylated interferon alpha-2 formulations in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Peginterferon alfa-2a (Primary)
- Indications Hepatitis B; Hepatitis C
- Focus Pharmacokinetics
- Acronyms FarmaPEG-I
- 31 Jul 2013 Status changed from active, no longer recruiting to completed as reported by Cuban Clinical Trial Registry record.
- 13 Feb 2013 Status changed from completed to active, no longer recruiting as reported by Cuban Clinical Trial Registry record.
- 13 Sep 2011 New trial record